The problem
Women in midlife can't find doctors trained in menopause, and specialist care is rarely covered by insurance
What they do
Insurance-covered virtual clinic for women's midlife care, starting with perimenopause and menopause
Traction $150M revenue run-rate (Feb 2026); 25,000+ patients a week; covered in all 50 states
Hiring trend
- Open roles
- 54
- Ops roles
- 3
- Headcount
- ~800
Headcount ~800, +83% YoY (LinkedIn est.); 50 open roles, mostly NP and clinical
Hiring in
- Palo Alto
- SF Bay Area
- San Francisco
- Remote
Glassdoor
2.5 ★ 72 reviews ↗Funding
- Last round
- $100M
- Stage
- Series D
- Date
- Feb 2026
Led by Goodwater Capital
- Hiring+254 open roles on the live job board (30+ roles = +2)
- Funding recency+1.5Series D · $100M, Feb 2026 (8 months ago): 6–12 months = +1, $100M+ round +0.5
- Traction+1.5Strong growth: $150M revenue run-rate (Feb 2026); 25,000+ patients a week; covered in all 50 states
- Red flags−11 significant flag in the last 24 months, −1 eachPatient-privacy class action over website tracking (N.C. v. Midi, 2025) plus a second federal suit; Feb 2026 NAD challenge made Midi drop a '91% relief' ad claim; Glassdoor 2.5 with 2026 reviews citing pay, productivity pressure and abrupt firings.CourtListener: N.C. v. Midi Health, privacy class action (Mar 2025) ↗ · BBB National Programs: NAD case, Midi discontinues menopause claims (Feb 2026) ↗ · Glassdoor: Midi Health reviews, 2.5 rating ↗
- Total4.02 + 1.5 + 1.5 − 1 = 4.0 → Tempo (3.5–4.24)
Distance (Half) is a separate read on how long the lead can last. It doesn't change the score.
Distance
Half · edge: cheaper at size
Category leader in insurance-covered menopause care ($150M run-rate, 50-state payer coverage reaching 45M women) whose clinician network and payer contracts get cheaper at size; Hims & Hers, Maven and cash-pay rivals keep it from a clear moat.
Sources: Midi: Series D, 45M women covered, 25,000 patients a week (Feb 2026) ↗ · Multiples: Midi $150M revenue at Series D ↗
Watch-outs
Patient-privacy class action over website tracking (N.C. v. Midi, 2025) plus a second federal suit; Feb 2026 NAD challenge made Midi drop a '91% relief' ad claim; Glassdoor 2.5 with 2026 reviews citing pay, productivity pressure and abrupt firings.
Sources: CourtListener: N.C. v. Midi Health, privacy class action (Mar 2025) ↗ · BBB National Programs: NAD case, Midi discontinues menopause claims (Feb 2026) ↗ · Glassdoor: Midi Health reviews, 2.5 rating ↗
Last checked Oct 25, 2026